<DOC>
	<DOCNO>NCT00343239</DOCNO>
	<brief_summary>Study objective : To determine Ro resection rate Docetaxel , cisplatin fluorouracil combination treatment neoadjuvant gastric carcinoma .</brief_summary>
	<brief_title>Docetaxel Locally Advanced Gastric Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologically proven gastric adenocarcinoma diagnosis Selected Stage IIB ( T3N0M0 ) , Stage IIIA ( T2aN2M0 , T2bN2M0 , T3N1M0 , T4N0M0 ) , Stage IIIB ( T3N2M0 ) select Stage IV ( T4 , NM0 , TN3M0 's ) . Clinical staging perform endoscopic ultrasound CT. Laparotomy laparoscopy prefer determine resectability peritoneal involvement . ECOG performance status 0 2 Acceptable hematological profile : WBC ( White Blood Cell ) count ≥4000/mm3 Platelet count ≥100 000 mm3 Hemoglobin ≥9 g/100 mL ( low , may include follow transfusion ) Adequate renal function Serum creatinine &lt; 1.2 mg/dl calculate creatinine clearance 24hours urine &gt; 60 mL/min . Adequate hepatic function Bilirubin &lt; UNL Transaminases ( ALT , AST ) &lt; 2.5 x UNL Alcaline phosphatase &lt; 2.5 x UNL Adequate pulmonary function Adequate cardiac function No prior chemotherapy gastric cancer Other histological type gastric cancer ( leiomyosarcoma , lymphoma ) adenocarcinoma Pregnant lactating patient Patients brain , bone metastasis ; peritoneal involvement Other serious underlie medical condition could impair ability patient participate study ( congestive heart failure , serious arrhythmia , uncontrolled diabetes mellitus , serious neuropathy ) , history myocardial infarction within 6 month prior study entry Previous current malignancy , exception carcinoma cervix uteri breast cancer basal cell skin cancer diseasefree period short 5 year Active infection serious disease Any experimental drug within 4week period prior study Contraindications use study drug ( e.g . history hypersensitivity content study drug ) The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>